On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...

PRESS RELEASE Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...